SMFM Special Statement: Who’s who in patient safety and quality for maternal healthcare in the United States - 26/07/20
On behalf of the
Patient Safety and Quality Committee, Society for Maternal-Fetal Medicine⁎
Abstract |
There are many organizations in the United States concerned with the improvement of patient safety and healthcare quality. In this overview, we provide a synopsis of the major entities whose work is relevant to maternal healthcare. For each organization, we summarize its mission, vision, major programs, and relationships with other entities. We include 13 entities with broad scope covering all types of healthcare; 9 organizations whose focus is maternal–child health; 6 women’s health professional organizations with committees on patient safety, quality, or both; 12 organizations that offer accreditation, certification, or special distinction based on quality; and 5 organizations that rate, rank, or report quality metrics.
Le texte complet de cet article est disponible en PDF.Key words : healthcare quality, organizations, patient safety
Plan
| Reprints will not be available. |
|
| All authors and Committee members have filed a conflict of interest disclosure delineating personal, professional, and/or business interests that might be perceived as a real or potential conflict of interest in relation to this publication. All conflicts have been resolved through a process approved by the Executive Board. The Society for Maternal-Fetal Medicine (SMFM) has neither solicited nor accepted any commercial involvement in the development of the content of this publication. |
|
| This document has undergone an internal peer review through a multilevel committee process within SMFM. This review involves critique and feedback from the SMFM Publications and Document Review Committees and final approval by the SMFM Executive Committee. SMFM accepts sole responsibility for document content. SMFM publications do not undergo editorial and peer review by the American Journal of Obstetrics and Gynecology. Publications are reviewed 18 to 24 months and issues updates are issued as needed. Further details regarding SMFM publications can be found at publications. |
|
| SMFM has adopted the use of the word “woman” (and the pronouns “she” and “her”) to apply to individuals who are assigned female sex at birth, including individuals who identify as men as well as nonbinary individuals who identify as both sexes or neither sexes. As gender-neutral language continues to evolve in the scientific and medical communities, SMFM will reassess this usage and make appropriate adjustments as necessary. |
|
| All questions or comments regarding the document should be referred to the SMFM Patient Safety and Quality Committee at smfm@smfm.org. |
Vol 223 - N° 1
P. B2-B15 - juillet 2020 Retour au numéro
Article précédent
- SMFM Divider Page
- SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth
- Society for Maternal-Fetal Medicine (SMFM) Publications Committee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?